OVERVIEW

The 2024 UCLA Advanced Lung Disease and Lung Transplantation Symposium is a hybrid virtual and in-person conference, organized by UCLA Health, the UCLA Center for Continuing Professional Development, and a multi-disciplinary group of speakers. The goal of the program is to provide updated information on state-of-the-art therapies available for patients with end-stage lung disease, including medical and interventional approaches, as well as lung transplantation.

TARGET AUDIENCE

This conference is targeted at Pulmonologists, critical care physicians, internists, cardiac and thoracic surgeons as well as allied health professionals who care for patients with advanced lung disease or refer patients for lung transplantation. 

LEARNING OBJECTIVES

At the conclusion of this activity, learners will be able to:

1. Understand the state of the art with respect to lung transplantation, including candidate selection, donor selection, donor lung preservation, and advances in research
2. Be familiar with important clinical considerations when critically ill patients with acute respiratory failure are being considered for lung transplantation
3. Be familiar with best practices for diagnosis and management of advanced COPD
4. Be familiar with best practices for diagnosis and management of bronchiectasis
5. Understand how respiratory viral infections can impact lung transplant candidates and recipients
6. have a better understanding of how cardiac disease can impact patients with advanced lung disease and those needing lung transplants
7. Be familiar with the diagnostic best practices when evaluating a patient with interstitial lung disease, including the use of multidisciplinary discussion.
8. Understand the importance of a multi-disciplinary expert team in the management of a patient after lung transplant and the role played by each team member 

ACCREDITATION

The David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The David Geffen School of Medicine at UCLA, designates this live activity for a maximum of 5.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The California State Board of Registered Nursing accepts courses approved for the AMA PRA Category 1 CreditsTM as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

For more information please visit the official event page.